I am a clinical geneticist and investigator with experience in design and execution of clinical studies for rare diseases, and in human subjects' protections. We have had an explosion of candidate and approved therapies for rare disorders in the past few years. In this session, we will be discussing new drugs available for treatment of rare neurological disorders. I look forward to an informative session that will foster discussion on this very timely topic.